AIkido Pharma (AIKI) Competitors $5.27 -0.13 (-2.41%) As of 06/9/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsInsider TradesSEC FilingsTrendsBuy This Stock AIKI vs. LUNA, ONMD, BIAF, ISPC, DKDCA, IQV, INCY, ICLR, MEDP, and CRLShould you be buying AIkido Pharma stock or one of its competitors? The main competitors of AIkido Pharma include Luna Innovations (LUNA), OneMedNet (ONMD), bioAffinity Technologies (BIAF), iSpecimen (ISPC), Data Knights Acquisition (DKDCA), IQVIA (IQV), Incyte (INCY), ICON Public (ICLR), Medpace (MEDP), and Charles River Laboratories International (CRL). These companies are all part of the "commercial physical research" industry. AIkido Pharma vs. Luna Innovations OneMedNet bioAffinity Technologies iSpecimen Data Knights Acquisition IQVIA Incyte ICON Public Medpace Charles River Laboratories International AIkido Pharma (NASDAQ:AIKI) and Luna Innovations (NASDAQ:LUNA) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their community ranking, profitability, earnings, valuation, media sentiment, analyst recommendations, risk, institutional ownership and dividends. Which has more volatility & risk, AIKI or LUNA? AIkido Pharma has a beta of 0.93, indicating that its share price is 7% less volatile than the S&P 500. Comparatively, Luna Innovations has a beta of 1.88, indicating that its share price is 88% more volatile than the S&P 500. Does the MarketBeat Community favor AIKI or LUNA? Luna Innovations received 98 more outperform votes than AIkido Pharma when rated by MarketBeat users. However, 63.92% of users gave AIkido Pharma an outperform vote while only 54.97% of users gave Luna Innovations an outperform vote. CompanyUnderperformOutperformAIkido PharmaOutperform Votes10163.92% Underperform Votes5736.08% Luna InnovationsOutperform Votes19954.97% Underperform Votes16345.03% Which has better valuation and earnings, AIKI or LUNA? Luna Innovations has higher revenue and earnings than AIkido Pharma. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAIkido Pharma$10K2,890.60-$7.17M-$3.88-1.36Luna Innovations$116.61M0.22$9.28MN/AN/A Do insiders & institutionals hold more shares of AIKI or LUNA? 10.9% of AIkido Pharma shares are held by institutional investors. Comparatively, 87.5% of Luna Innovations shares are held by institutional investors. 8.6% of AIkido Pharma shares are held by company insiders. Comparatively, 7.6% of Luna Innovations shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Does the media prefer AIKI or LUNA? In the previous week, Luna Innovations had 3 more articles in the media than AIkido Pharma. MarketBeat recorded 3 mentions for Luna Innovations and 0 mentions for AIkido Pharma. Luna Innovations' average media sentiment score of 0.42 beat AIkido Pharma's score of 0.00 indicating that Luna Innovations is being referred to more favorably in the news media. Company Overall Sentiment AIkido Pharma Neutral Luna Innovations Neutral Is AIKI or LUNA more profitable? Luna Innovations' return on equity of 0.00% beat AIkido Pharma's return on equity.Company Net Margins Return on Equity Return on Assets AIkido PharmaN/A -18.21% -16.94% Luna Innovations N/A N/A N/A SummaryLuna Innovations beats AIkido Pharma on 9 of the 12 factors compared between the two stocks. Get AIkido Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for AIKI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AIKI vs. The Competition Export to ExcelMetricAIkido PharmaCommercial physical research IndustryMedical SectorNASDAQ ExchangeMarket Cap$28.91M$3.36B$5.57B$8.67BDividend YieldN/A2.24%5.27%4.19%P/E Ratio-1.36122.0627.2020.17Price / Sales2,890.60161.53412.92161.90Price / CashN/A34.5738.2534.64Price / Book0.272.597.114.72Net Income-$7.17M$118.81M$3.23B$247.80M7 Day Performance17.63%5.65%4.61%3.36%1 Month Performance-12.02%11.26%13.35%9.71%1 Year Performance150.95%-16.36%31.75%14.41% AIkido Pharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AIKIAIkido PharmaN/A$5.27-2.4%N/A+159.1%$28.91M$10,000.00-1.364High Trading VolumeLUNALuna Innovations0.4277 of 5 stars$0.75+7.1%N/A-78.7%$25.47M$116.61M0.00390Gap DownONMDOneMedNet0.2069 of 5 stars$0.37-3.9%N/A-74.3%$11.16M$532,000.00-1.112Gap DownBIAFbioAffinity Technologies2.4466 of 5 stars$0.28+7.6%$6.00+2,023.1%-87.5%$7.90M$8.81M-0.3410Gap UpISPCiSpecimen0.6314 of 5 stars$1.28+9.9%N/A+218.4%$3.18M$8.06M-0.0760DKDCAData Knights AcquisitionN/A$0.38-5.0%N/A-77.9%$1.97MN/A-2.002Gap DownHigh Trading VolumeIQVIQVIA4.9162 of 5 stars$142.74+2.6%$226.32+58.5%-29.7%$24.69B$15.50B19.0386,000Positive NewsINCYIncyte4.302 of 5 stars$67.11+2.8%$72.53+8.1%+18.1%$12.99B$4.41B248.562,320Positive NewsHigh Trading VolumeICLRICON Public4.3849 of 5 stars$133.76+3.8%$213.08+59.3%-56.2%$10.80B$8.19B14.0441,100MEDPMedpace4.7151 of 5 stars$306.07+2.8%$349.30+14.1%-25.6%$8.80B$2.16B24.235,200Positive NewsCRLCharles River Laboratories International4.4661 of 5 stars$138.71+2.7%$171.85+23.9%-31.3%$6.81B$4.02B924.7521,400 Related Companies and Tools Related Companies Luna Innovations Alternatives OneMedNet Alternatives bioAffinity Technologies Alternatives iSpecimen Alternatives Data Knights Acquisition Alternatives IQVIA Alternatives Incyte Alternatives ICON Public Alternatives Medpace Alternatives Charles River Laboratories International Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AIKI) was last updated on 6/10/2025 by MarketBeat.com Staff From Our PartnersElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredGet Ready for Elon Musk’s BIGGEST Comeback YetTesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored50-year legend: Here’s exact day stocks will crashGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AIkido Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AIkido Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.